Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BTDS versus standard treatment in elderly patients with hip and/or knee osteoarthritis pain
2005-004279-39Phase 4Completed
- Sponsor
- Napp Pharmaceuticals
- Start
- Feb 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of buprenorphine, Paracetamol + codeine, acetaminophen and codeine in osteoarthritis (OA) (2 arms), sponsored by Napp Pharmaceuticals. Primary endpoint: Average daily pain score. Started Feb 2006; status: completed.
02
Drugs
buprenorphineParacetamol + codeineacetaminophencodeine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2005-004279-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004279-39.